Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SYNRG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF331 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APMAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXO9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DSTYK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF220 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELAC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NETO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HTT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIOK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C1orf21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNOT9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABCF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JADE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPH7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASB6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP7D3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on